
|Podcasts|June 17, 2022
Pharmacy Focus: Psychedelic Pharmacy - Psilocybin-Assisted Therapy for Binge Eating Disorder
Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.
Advertisement
This month, we spoke with Jim Gilligan, PhD, to learn about a phase 2 study investigating the use of psilocybin-assisted therapy for the treatment of binge eating disorder.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































